

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.26159929 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.19685469 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 6.06812953 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.76370648 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.64406368 |
| 6 | glutamate secretion (GO:0014047) | 5.43967436 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.29621257 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.25880078 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.10213316 |
| 10 | regulation of synaptic vesicle transport (GO:1902803) | 4.99871995 |
| 11 | vocalization behavior (GO:0071625) | 4.80635690 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.73695069 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.72702750 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.72702750 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.71668640 |
| 16 | cellular potassium ion homeostasis (GO:0030007) | 4.64025349 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63335489 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63335489 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 4.63335489 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63335489 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.63335489 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63335489 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.62384587 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.61269443 |
| 25 | response to peptidoglycan (GO:0032494) | 4.60370174 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.47923520 |
| 27 | protein localization to synapse (GO:0035418) | 4.47120636 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 4.46997854 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.44590580 |
| 30 | neuronal action potential propagation (GO:0019227) | 4.25862278 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.23688393 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 4.17403950 |
| 33 | sodium ion export (GO:0071436) | 4.12967372 |
| 34 | proline transport (GO:0015824) | 4.08532137 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.08490761 |
| 36 | exploration behavior (GO:0035640) | 4.05529958 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.05185034 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.03689273 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 4.01155582 |
| 40 | cellular extravasation (GO:0045123) | 4.00712067 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.96984498 |
| 42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91788756 |
| 43 | synaptic vesicle endocytosis (GO:0048488) | 3.90744551 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 3.84750888 |
| 45 | detection of other organism (GO:0098543) | 3.83779402 |
| 46 | neuron cell-cell adhesion (GO:0007158) | 3.82955498 |
| 47 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.82620097 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 3.79542573 |
| 49 | neuron-neuron synaptic transmission (GO:0007270) | 3.76945364 |
| 50 | neurotransmitter transport (GO:0006836) | 3.76351895 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.74491447 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.72498803 |
| 53 | glutamate receptor signaling pathway (GO:0007215) | 3.71737121 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 3.71593477 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70770285 |
| 56 | neuromuscular process controlling posture (GO:0050884) | 3.66574706 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.65563109 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.64806482 |
| 59 | macrophage activation (GO:0042116) | 3.63482015 |
| 60 | long-term memory (GO:0007616) | 3.59703057 |
| 61 | detection of external biotic stimulus (GO:0098581) | 3.59148292 |
| 62 | microglial cell activation (GO:0001774) | 3.58052417 |
| 63 | positive regulation of membrane potential (GO:0045838) | 3.54802604 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.54732272 |
| 65 | gamma-aminobutyric acid transport (GO:0015812) | 3.54222401 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.52915704 |
| 67 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.51927490 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.49686605 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.45461752 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.44817854 |
| 71 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.44366240 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 3.44353732 |
| 73 | regulation of vesicle fusion (GO:0031338) | 3.43489335 |
| 74 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.42480476 |
| 75 | vesicle transport along microtubule (GO:0047496) | 3.39015612 |
| 76 | cell communication by electrical coupling (GO:0010644) | 3.38824616 |
| 77 | detection of bacterium (GO:0016045) | 3.38384414 |
| 78 | granulocyte activation (GO:0036230) | 3.38333703 |
| 79 | regulation of neurotransmitter levels (GO:0001505) | 3.38214309 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36385425 |
| 81 | regulation of synaptic plasticity (GO:0048167) | 3.34888803 |
| 82 | neutrophil mediated immunity (GO:0002446) | 3.34575609 |
| 83 | regulation of postsynaptic membrane potential (GO:0060078) | 3.32880421 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 3.32737815 |
| 85 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.30073906 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29745004 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.29745004 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29600841 |
| 89 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.29501760 |
| 90 | regulation of neurotransmitter transport (GO:0051588) | 3.28164576 |
| 91 | neutrophil activation (GO:0042119) | 3.25370015 |
| 92 | glycine transport (GO:0015816) | 3.24827227 |
| 93 | response to pheromone (GO:0019236) | 3.22715678 |
| 94 | respiratory burst (GO:0045730) | 3.21638745 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20211917 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.20050018 |
| 97 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19944707 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 3.19525710 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.18902234 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18769741 |
| 101 | glycosphingolipid catabolic process (GO:0046479) | 3.18722523 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 3.18513546 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.17958118 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17368778 |
| 105 | synaptic vesicle transport (GO:0048489) | 3.16077417 |
| 106 | establishment of synaptic vesicle localization (GO:0097480) | 3.16077417 |
| 107 | innervation (GO:0060384) | 3.14780320 |
| 108 | detection of biotic stimulus (GO:0009595) | 3.13909385 |
| 109 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.13885030 |
| 110 | response to histamine (GO:0034776) | 3.13372189 |
| 111 | membrane depolarization during action potential (GO:0086010) | 3.12683953 |
| 112 | response to auditory stimulus (GO:0010996) | 3.11495060 |
| 113 | regulation of regulated secretory pathway (GO:1903305) | 3.10874424 |
| 114 | mating behavior (GO:0007617) | 3.10290640 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 3.10093770 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10024115 |
| 117 | response to host immune response (GO:0052572) | 3.10024115 |
| 118 | potassium ion homeostasis (GO:0055075) | 3.08848066 |
| 119 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08742089 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08290381 |
| 121 | regulation of mast cell activation (GO:0033003) | 3.07042418 |
| 122 | amino sugar catabolic process (GO:0046348) | 3.02051078 |
| 123 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.99344546 |
| 124 | * phagosome maturation (GO:0090382) | 2.98971419 |
| 125 | positive regulation of synaptic transmission (GO:0050806) | 2.98809007 |
| 126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98469375 |
| 127 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97990256 |
| 128 | synaptic transmission (GO:0007268) | 2.97880019 |
| 129 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97209452 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97034941 |
| 131 | membrane hyperpolarization (GO:0060081) | 2.96843749 |
| 132 | prepulse inhibition (GO:0060134) | 2.96590762 |
| 133 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.95251762 |
| 134 | establishment of vesicle localization (GO:0051650) | 2.95144497 |
| 135 | negative regulation of interleukin-17 production (GO:0032700) | 2.94424749 |
| 136 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93934884 |
| 137 | * transferrin transport (GO:0033572) | 2.92011618 |
| 138 | membrane depolarization (GO:0051899) | 2.91821260 |
| 139 | positive regulation of leukocyte degranulation (GO:0043302) | 2.91065933 |
| 140 | germinal center formation (GO:0002467) | 2.90897497 |
| 141 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90737408 |
| 142 | organelle transport along microtubule (GO:0072384) | 2.90666572 |
| 143 | regulation of exocytosis (GO:0017157) | 2.90534056 |
| 144 | cerebellar Purkinje cell layer development (GO:0021680) | 2.89571351 |
| 145 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.89408344 |
| 146 | regulation of synaptic transmission (GO:0050804) | 2.89382706 |
| 147 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.89242608 |
| 148 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.88667642 |
| 149 | oligosaccharide catabolic process (GO:0009313) | 2.88367426 |
| 150 | positive regulation of exocytosis (GO:0045921) | 2.87784869 |
| 151 | regulation of ARF protein signal transduction (GO:0032012) | 2.87723182 |
| 152 | axon cargo transport (GO:0008088) | 2.87646712 |
| 153 | synapse assembly (GO:0007416) | 2.87354154 |
| 154 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.87299186 |
| 155 | neuron recognition (GO:0008038) | 2.86432885 |
| 156 | striatum development (GO:0021756) | 2.86104600 |
| 157 | glycolipid catabolic process (GO:0019377) | 2.85344583 |
| 158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.85178709 |
| 159 | long term synaptic depression (GO:0060292) | 2.84993858 |
| 160 | dendritic spine morphogenesis (GO:0060997) | 2.84892305 |
| 161 | positive regulation of vesicle fusion (GO:0031340) | 2.84472555 |
| 162 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.83237584 |
| 163 | positive regulation of regulated secretory pathway (GO:1903307) | 2.83042663 |
| 164 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.82950041 |
| 165 | T-helper 1 type immune response (GO:0042088) | 2.81412539 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80916772 |
| 167 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79951538 |
| 168 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75081708 |
| 169 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.72034012 |
| 170 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71795537 |
| 171 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.70924812 |
| 172 | neutrophil chemotaxis (GO:0030593) | 2.70329918 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70073648 |
| 174 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.69999569 |
| 175 | negative regulation of T cell mediated immunity (GO:0002710) | 2.69758668 |
| 176 | leukocyte aggregation (GO:0070486) | 2.67473762 |
| 177 | response to muramyl dipeptide (GO:0032495) | 2.66541722 |
| 178 | regulation of beta-amyloid formation (GO:1902003) | 2.66199983 |
| 179 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64910734 |
| 180 | response to host (GO:0075136) | 2.64910734 |
| 181 | response to host defenses (GO:0052200) | 2.64910734 |
| 182 | regulation of cellular amide metabolic process (GO:0034248) | 2.64030955 |
| 183 | neutrophil migration (GO:1990266) | 2.63420249 |
| 184 | myeloid leukocyte activation (GO:0002274) | 2.63377464 |
| 185 | regulation of T cell tolerance induction (GO:0002664) | 2.60708810 |
| 186 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.58407981 |
| 187 | regulation of macrophage cytokine production (GO:0010935) | 2.55905981 |
| 188 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54551447 |
| 189 | defense response to protozoan (GO:0042832) | 2.53605525 |
| 190 | protein localization to endosome (GO:0036010) | 2.51449341 |
| 191 | regulation of tolerance induction (GO:0002643) | 2.51421918 |
| 192 | ceramide catabolic process (GO:0046514) | 2.51356373 |
| 193 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49614102 |
| 194 | N-acetylneuraminate metabolic process (GO:0006054) | 2.49157950 |
| 195 | positive regulation of type 2 immune response (GO:0002830) | 2.49037365 |
| 196 | type I interferon signaling pathway (GO:0060337) | 2.47164052 |
| 197 | cellular response to type I interferon (GO:0071357) | 2.47164052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.24414939 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67081098 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.66833259 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60938499 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72150239 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.55844384 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.48156009 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10597915 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 3.10458125 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07880981 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03160648 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.99132711 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.94904236 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93310390 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.89037291 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.80449895 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75908079 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66552404 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.64630804 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.62363350 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.59622658 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53598491 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53158688 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51206366 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48735289 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48735289 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.48437741 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47412725 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.42371642 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38936518 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33750571 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30333063 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28911028 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.28500854 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27315129 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17749053 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14255036 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13872691 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12489610 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11617453 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07576381 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02240437 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01146297 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98787455 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91114387 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90804202 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90359487 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87504234 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82530833 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79941521 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79445003 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77926588 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74294559 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72082578 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70276082 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67084032 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66733224 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66622260 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66027556 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65628172 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65185674 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58549683 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58296179 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57285559 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57130942 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56748726 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56004399 |
| 68 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55513869 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55266251 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54231024 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53435318 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53312222 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53116165 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52641873 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49504494 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47013288 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45708459 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43974024 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43452924 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42981490 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42535347 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38613199 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38214191 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34941163 |
| 85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33662648 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31433530 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30907070 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29666168 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28984276 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.28167428 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27765431 |
| 92 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27184618 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26699066 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26583514 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25717790 |
| 96 | AR_19668381_ChIP-Seq_PC3_Human | 1.25370974 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24781345 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24201824 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23454007 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23157442 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22781724 |
| 102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22734130 |
| 103 | MAF_26560356_Chip-Seq_TH1_Human | 1.22346217 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20616357 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19036701 |
| 106 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17942435 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16035664 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15829057 |
| 109 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15502315 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14992871 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14902719 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14836604 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14830984 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14556405 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14538090 |
| 116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14531551 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14386547 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13349803 |
| 119 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12988188 |
| 120 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12490690 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11716719 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11349117 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11015656 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10448249 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10127184 |
| 126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03984871 |
| 127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03876555 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03147102 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02981467 |
| 130 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02449990 |
| 131 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01501348 |
| 132 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00093377 |
| 133 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99841916 |
| 134 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99820205 |
| 135 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99810770 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99721980 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98630584 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97554505 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96819320 |
| 140 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95292522 |
| 141 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95182049 |
| 142 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95093834 |
| 143 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95047869 |
| 144 | MYB_26560356_Chip-Seq_TH1_Human | 0.94907291 |
| 145 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93849555 |
| 146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93752811 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93529784 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92299809 |
| 149 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91255599 |
| 150 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91212931 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90840413 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89934065 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89811558 |
| 154 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89164954 |
| 155 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88104728 |
| 156 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88060707 |
| 157 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87543835 |
| 158 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87534267 |
| 159 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87144863 |
| 160 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86448012 |
| 161 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85312875 |
| 162 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84792058 |
| 163 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84011060 |
| 164 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83930648 |
| 165 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.83067521 |
| 166 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82291807 |
| 167 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81740550 |
| 168 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80309436 |
| 169 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80183653 |
| 170 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79970158 |
| 171 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79659018 |
| 172 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79443917 |
| 173 | MAF_26560356_Chip-Seq_TH2_Human | 0.78910104 |
| 174 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78028662 |
| 175 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78021394 |
| 176 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77791255 |
| 177 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75602264 |
| 178 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75313430 |
| 179 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74010254 |
| 180 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73813913 |
| 181 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72347605 |
| 182 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71730498 |
| 183 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64276277 |
| 184 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.60017505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.22997998 |
| 2 | MP0003880_abnormal_central_pattern | 4.39820547 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.01329018 |
| 4 | MP0003724_increased_susceptibility_to | 3.96171494 |
| 5 | MP0004270_analgesia | 3.55027669 |
| 6 | MP0006082_CNS_inflammation | 3.39518729 |
| 7 | MP0009046_muscle_twitch | 3.27151138 |
| 8 | MP0002064_seizures | 3.21851832 |
| 9 | MP0009745_abnormal_behavioral_response | 3.21657517 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.21035169 |
| 11 | MP0003436_decreased_susceptibility_to | 3.18133466 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.04095217 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.89426516 |
| 14 | MP0002419_abnormal_innate_immunity | 2.80013141 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.68747094 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.64535124 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.53063519 |
| 18 | MP0009785_altered_susceptibility_to | 2.51655770 |
| 19 | MP0002822_catalepsy | 2.49536985 |
| 20 | MP0002272_abnormal_nervous_system | 2.48624282 |
| 21 | MP0005671_abnormal_response_to | 2.45456620 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.40696338 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.39585104 |
| 24 | MP0002736_abnormal_nociception_after | 2.37895717 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.31920270 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.31446298 |
| 27 | MP0005025_abnormal_response_to | 2.30500208 |
| 28 | MP0002909_abnormal_adrenal_gland | 2.30232562 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.29897819 |
| 30 | MP0001501_abnormal_sleep_pattern | 2.26969959 |
| 31 | MP0001486_abnormal_startle_reflex | 2.23092559 |
| 32 | MP0005387_immune_system_phenotype | 2.17646465 |
| 33 | MP0001790_abnormal_immune_system | 2.17646465 |
| 34 | MP0002733_abnormal_thermal_nociception | 2.13526586 |
| 35 | MP0009840_abnormal_foam_cell | 2.11452844 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 2.10982179 |
| 37 | MP0004858_abnormal_nervous_system | 2.06133248 |
| 38 | MP0008260_abnormal_autophagy | 2.05614097 |
| 39 | MP0001970_abnormal_pain_threshold | 2.05527934 |
| 40 | MP0001440_abnormal_grooming_behavior | 2.02088931 |
| 41 | MP0010386_abnormal_urinary_bladder | 2.01650502 |
| 42 | MP0003329_amyloid_beta_deposits | 1.98652785 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.98536267 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.95518416 |
| 45 | MP0002723_abnormal_immune_serum | 1.94294454 |
| 46 | MP0001800_abnormal_humoral_immune | 1.87458391 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.87174425 |
| 48 | MP0008569_lethality_at_weaning | 1.86428304 |
| 49 | MP0003879_abnormal_hair_cell | 1.86105063 |
| 50 | MP0000685_abnormal_immune_system | 1.84275937 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.80112718 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.78132538 |
| 53 | MP0001819_abnormal_immune_cell | 1.76244892 |
| 54 | MP0000343_altered_response_to | 1.71505321 |
| 55 | MP0001984_abnormal_olfaction | 1.69520680 |
| 56 | MP0002184_abnormal_innervation | 1.69458078 |
| 57 | MP0009764_decreased_sensitivity_to | 1.65955909 |
| 58 | MP0005451_abnormal_body_composition | 1.62825071 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.62677722 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.61615594 |
| 61 | MP0004924_abnormal_behavior | 1.61615594 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.59977116 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.59504703 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.56836621 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.55786925 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.53211104 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.51792497 |
| 68 | MP0009278_abnormal_bone_marrow | 1.49261700 |
| 69 | MP0003633_abnormal_nervous_system | 1.48681211 |
| 70 | MP0000955_abnormal_spinal_cord | 1.46504345 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.46478603 |
| 72 | MP0003787_abnormal_imprinting | 1.42684102 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.42337299 |
| 74 | MP0000569_abnormal_digit_pigmentation | 1.42312759 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.39631212 |
| 76 | MP0003122_maternal_imprinting | 1.38789086 |
| 77 | MP0002405_respiratory_system_inflammati | 1.38157241 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 1.38126640 |
| 79 | MP0004947_skin_inflammation | 1.36869402 |
| 80 | MP0002066_abnormal_motor_capabilities/c | 1.36654179 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.36591424 |
| 82 | MP0000013_abnormal_adipose_tissue | 1.35801442 |
| 83 | MP0005166_decreased_susceptibility_to | 1.35508059 |
| 84 | MP0002090_abnormal_vision | 1.32912638 |
| 85 | MP0008469_abnormal_protein_level | 1.27560135 |
| 86 | MP0004885_abnormal_endolymph | 1.26819711 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.25964102 |
| 88 | MP0000604_amyloidosis | 1.24866937 |
| 89 | MP0000778_abnormal_nervous_system | 1.24167132 |
| 90 | MP0000015_abnormal_ear_pigmentation | 1.23054026 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.22100979 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.22100979 |
| 93 | MP0002229_neurodegeneration | 1.19964691 |
| 94 | MP0003828_pulmonary_edema | 1.19415992 |
| 95 | MP0000716_abnormal_immune_system | 1.19087979 |
| 96 | MP0010155_abnormal_intestine_physiology | 1.18066413 |
| 97 | MP0003631_nervous_system_phenotype | 1.17196964 |
| 98 | MP0004043_abnormal_pH_regulation | 1.14394216 |
| 99 | MP0004142_abnormal_muscle_tone | 1.10322841 |
| 100 | MP0003448_altered_tumor_morphology | 1.09962931 |
| 101 | MP0003283_abnormal_digestive_organ | 1.08883393 |
| 102 | MP0008961_abnormal_basal_metabolism | 1.08560271 |
| 103 | MP0001853_heart_inflammation | 1.06975218 |
| 104 | MP0003075_altered_response_to | 1.05466527 |
| 105 | MP0003634_abnormal_glial_cell | 1.04114596 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 1.02646774 |
| 107 | MP0003690_abnormal_glial_cell | 1.01179918 |
| 108 | MP0004883_abnormal_blood_vessel | 1.01075969 |
| 109 | MP0005535_abnormal_body_temperature | 1.00788791 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.99238974 |
| 111 | MP0001905_abnormal_dopamine_level | 0.98985811 |
| 112 | MP0002398_abnormal_bone_marrow | 0.98275151 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.97868273 |
| 114 | MP0001529_abnormal_vocalization | 0.96999140 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.95661505 |
| 116 | MP0004233_abnormal_muscle_weight | 0.93494607 |
| 117 | MP0005164_abnormal_response_to | 0.92946360 |
| 118 | MP0000858_altered_metastatic_potential | 0.92069251 |
| 119 | MP0008004_abnormal_stomach_pH | 0.91561685 |
| 120 | MP0002152_abnormal_brain_morphology | 0.91305420 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.89238599 |
| 122 | MP0008872_abnormal_physiological_respon | 0.87522796 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.87380967 |
| 124 | MP0003195_calcinosis | 0.84503378 |
| 125 | MP0000371_diluted_coat_color | 0.84161884 |
| 126 | MP0002429_abnormal_blood_cell | 0.83524105 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.83133684 |
| 128 | MP0005167_abnormal_blood-brain_barrier | 0.82593494 |
| 129 | MP0003866_abnormal_defecation | 0.82348882 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.81980162 |
| 131 | MP0005253_abnormal_eye_physiology | 0.81856032 |
| 132 | MP0005499_abnormal_olfactory_system | 0.81172452 |
| 133 | MP0005394_taste/olfaction_phenotype | 0.81172452 |
| 134 | MP0004510_myositis | 0.81105301 |
| 135 | MP0000751_myopathy | 0.80996020 |
| 136 | MP0000465_gastrointestinal_hemorrhage | 0.80317735 |
| 137 | MP0008874_decreased_physiological_sensi | 0.79538365 |
| 138 | MP0003632_abnormal_nervous_system | 0.79229848 |
| 139 | MP0002332_abnormal_exercise_endurance | 0.78709496 |
| 140 | MP0002722_abnormal_immune_system | 0.76780289 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.74153661 |
| 142 | MP0001851_eye_inflammation | 0.72135005 |
| 143 | MP0001188_hyperpigmentation | 0.71585288 |
| 144 | MP0010234_abnormal_vibrissa_follicle | 0.71506089 |
| 145 | MP0001963_abnormal_hearing_physiology | 0.70757149 |
| 146 | MP0004742_abnormal_vestibular_system | 0.70319992 |
| 147 | MP0006054_spinal_hemorrhage | 0.69770722 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.67776918 |
| 149 | MP0004145_abnormal_muscle_electrophysio | 0.67737601 |
| 150 | MP0009763_increased_sensitivity_to | 0.67576510 |
| 151 | MP0001177_atelectasis | 0.67445281 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.66942428 |
| 153 | MP0003795_abnormal_bone_structure | 0.66156460 |
| 154 | MP0003045_fibrosis | 0.64954306 |
| 155 | MP0005174_abnormal_tail_pigmentation | 0.64447475 |
| 156 | MP0003453_abnormal_keratinocyte_physiol | 0.64052959 |
| 157 | MP0004085_abnormal_heartbeat | 0.63522428 |
| 158 | MP0002876_abnormal_thyroid_physiology | 0.61796713 |
| 159 | MP0000631_abnormal_neuroendocrine_gland | 0.60502063 |
| 160 | MP0004215_abnormal_myocardial_fiber | 0.59074225 |
| 161 | MP0000920_abnormal_myelination | 0.58562988 |
| 162 | MP0001765_abnormal_ion_homeostasis | 0.55930081 |
| 163 | MP0001664_abnormal_digestion | 0.55397006 |
| 164 | MP0003123_paternal_imprinting | 0.53102695 |
| 165 | MP0005310_abnormal_salivary_gland | 0.52850262 |
| 166 | MP0003303_peritoneal_inflammation | 0.52131228 |
| 167 | MP0002693_abnormal_pancreas_physiology | 0.51864334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.70191782 |
| 2 | Myokymia (HP:0002411) | 5.99650761 |
| 3 | Visual hallucinations (HP:0002367) | 5.50333929 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.22837993 |
| 5 | Focal seizures (HP:0007359) | 5.17693068 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.11953537 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.95006915 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.75356703 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.71468227 |
| 10 | Atonic seizures (HP:0010819) | 4.63034134 |
| 11 | Absence seizures (HP:0002121) | 4.34051173 |
| 12 | Febrile seizures (HP:0002373) | 4.26930533 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 4.16400314 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 4.02151412 |
| 15 | Orchitis (HP:0100796) | 3.98889856 |
| 16 | Dialeptic seizures (HP:0011146) | 3.93559070 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.91847443 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.91036485 |
| 19 | Optic neuritis (HP:0100653) | 3.91036485 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89025467 |
| 21 | Myositis (HP:0100614) | 3.83900464 |
| 22 | Loss of speech (HP:0002371) | 3.83456257 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.78198419 |
| 24 | Stomatitis (HP:0010280) | 3.71036083 |
| 25 | Action tremor (HP:0002345) | 3.61902583 |
| 26 | Disinhibition (HP:0000734) | 3.58228957 |
| 27 | Depression (HP:0000716) | 3.43876852 |
| 28 | Mutism (HP:0002300) | 3.38709517 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.21288048 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.16702976 |
| 31 | Postural instability (HP:0002172) | 3.16579744 |
| 32 | Ankle clonus (HP:0011448) | 3.14384303 |
| 33 | Recurrent skin infections (HP:0001581) | 3.10861647 |
| 34 | Truncal ataxia (HP:0002078) | 3.07345964 |
| 35 | Pheochromocytoma (HP:0002666) | 3.00002044 |
| 36 | Poor eye contact (HP:0000817) | 2.98390123 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.98021211 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.95759588 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93436731 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93436731 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93436731 |
| 42 | Papilledema (HP:0001085) | 2.91838161 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.85679909 |
| 44 | Anxiety (HP:0000739) | 2.84433637 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84269732 |
| 46 | Obstructive lung disease (HP:0006536) | 2.84269732 |
| 47 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.81251564 |
| 48 | Gaze-evoked nystagmus (HP:0000640) | 2.79175455 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77920537 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.77920537 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.77910143 |
| 52 | Impaired social interactions (HP:0000735) | 2.76206137 |
| 53 | Abnormal social behavior (HP:0012433) | 2.76206137 |
| 54 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.75733473 |
| 55 | Amyloidosis (HP:0011034) | 2.71339456 |
| 56 | Gingivitis (HP:0000230) | 2.69824864 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.69525955 |
| 58 | Dysmetria (HP:0001310) | 2.68935352 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.68833119 |
| 60 | Broad-based gait (HP:0002136) | 2.67945811 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.66758487 |
| 62 | Neuroendocrine neoplasm (HP:0100634) | 2.66334498 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.63479705 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.61103134 |
| 65 | Diplopia (HP:0000651) | 2.61103134 |
| 66 | Abnormality of the lower motor neuron (HP:0002366) | 2.60990499 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.60747260 |
| 68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59874000 |
| 69 | Bradykinesia (HP:0002067) | 2.59675004 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.56255141 |
| 71 | Impaired smooth pursuit (HP:0007772) | 2.55604715 |
| 72 | Amblyopia (HP:0000646) | 2.52158031 |
| 73 | Polyphagia (HP:0002591) | 2.51961728 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.51565937 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.50254795 |
| 76 | Agitation (HP:0000713) | 2.50050223 |
| 77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48575395 |
| 78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48575395 |
| 79 | Genetic anticipation (HP:0003743) | 2.47814517 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.47737765 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.47353762 |
| 82 | Progressive inability to walk (HP:0002505) | 2.44226029 |
| 83 | Hemiparesis (HP:0001269) | 2.41521562 |
| 84 | Resting tremor (HP:0002322) | 2.39654134 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.39083131 |
| 86 | Urticaria (HP:0001025) | 2.37818158 |
| 87 | Torticollis (HP:0000473) | 2.37101390 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.36673652 |
| 89 | Central scotoma (HP:0000603) | 2.36273829 |
| 90 | Urinary urgency (HP:0000012) | 2.35657043 |
| 91 | Hemoptysis (HP:0002105) | 2.35396633 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.35193844 |
| 93 | Meningitis (HP:0001287) | 2.34925659 |
| 94 | Hyperventilation (HP:0002883) | 2.34281082 |
| 95 | Hypsarrhythmia (HP:0002521) | 2.33465356 |
| 96 | Hemiplegia (HP:0002301) | 2.33083860 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 2.32925255 |
| 98 | Vasculitis (HP:0002633) | 2.30866342 |
| 99 | Episodic fever (HP:0001954) | 2.30128284 |
| 100 | T lymphocytopenia (HP:0005403) | 2.28617814 |
| 101 | Agnosia (HP:0010524) | 2.27370248 |
| 102 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26914917 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26787054 |
| 104 | Failure to thrive in infancy (HP:0001531) | 2.26692695 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.24671121 |
| 106 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22910245 |
| 107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22910245 |
| 108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22910245 |
| 109 | Increased CSF protein (HP:0002922) | 2.22336018 |
| 110 | Status epilepticus (HP:0002133) | 2.22202689 |
| 111 | Excessive salivation (HP:0003781) | 2.21953605 |
| 112 | Drooling (HP:0002307) | 2.21953605 |
| 113 | Dysmetric saccades (HP:0000641) | 2.20548396 |
| 114 | Memory impairment (HP:0002354) | 2.18445031 |
| 115 | Hypercortisolism (HP:0001578) | 2.18417580 |
| 116 | Focal dystonia (HP:0004373) | 2.17745704 |
| 117 | Encephalitis (HP:0002383) | 2.16926400 |
| 118 | Spastic gait (HP:0002064) | 2.16603343 |
| 119 | Hematochezia (HP:0002573) | 2.15893607 |
| 120 | Intention tremor (HP:0002080) | 2.15318462 |
| 121 | Purpura (HP:0000979) | 2.15211023 |
| 122 | Stereotypic behavior (HP:0000733) | 2.15014517 |
| 123 | Slow saccadic eye movements (HP:0000514) | 2.14301522 |
| 124 | Scanning speech (HP:0002168) | 2.14086153 |
| 125 | Peripheral hypomyelination (HP:0007182) | 2.12053297 |
| 126 | Apathy (HP:0000741) | 2.11116207 |
| 127 | Increased IgE level (HP:0003212) | 2.10476195 |
| 128 | Myocardial infarction (HP:0001658) | 2.10377604 |
| 129 | Generalized myoclonic seizures (HP:0002123) | 2.08744184 |
| 130 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07759418 |
| 131 | Upper motor neuron abnormality (HP:0002127) | 2.06986892 |
| 132 | Limb dystonia (HP:0002451) | 2.05485959 |
| 133 | Abnormality of T cell number (HP:0011839) | 2.04923931 |
| 134 | Petechiae (HP:0000967) | 2.04623016 |
| 135 | Rigidity (HP:0002063) | 2.03132822 |
| 136 | Menstrual irregularities (HP:0000858) | 2.02699187 |
| 137 | Termporal pattern (HP:0011008) | 2.01804283 |
| 138 | Insidious onset (HP:0003587) | 2.01804283 |
| 139 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.00511941 |
| 140 | Leukocytosis (HP:0001974) | 1.99932531 |
| 141 | Hepatosplenomegaly (HP:0001433) | 1.98711465 |
| 142 | Lower limb muscle weakness (HP:0007340) | 1.98372466 |
| 143 | Cellulitis (HP:0100658) | 1.98220438 |
| 144 | Gingival bleeding (HP:0000225) | 1.97453898 |
| 145 | Axonal loss (HP:0003447) | 1.97433756 |
| 146 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97350323 |
| 147 | Gait ataxia (HP:0002066) | 1.96353101 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.95628071 |
| 149 | Congenital stationary night blindness (HP:0007642) | 1.95458130 |
| 150 | Craniofacial dystonia (HP:0012179) | 1.95062729 |
| 151 | Psychosis (HP:0000709) | 1.94906216 |
| 152 | Diminished motivation (HP:0000745) | 1.94661079 |
| 153 | Nuclear cataract (HP:0100018) | 1.94102903 |
| 154 | Osteomyelitis (HP:0002754) | 1.93973594 |
| 155 | Abnormality of macular pigmentation (HP:0008002) | 1.93806375 |
| 156 | Abnormality of the periventricular white matter (HP:0002518) | 1.93624691 |
| 157 | Hypoventilation (HP:0002791) | 1.93393245 |
| 158 | Chest pain (HP:0100749) | 1.92556625 |
| 159 | Inability to walk (HP:0002540) | 1.92544842 |
| 160 | Pulmonary embolism (HP:0002204) | 1.91779844 |
| 161 | Global brain atrophy (HP:0002283) | 1.91770152 |
| 162 | Fetal akinesia sequence (HP:0001989) | 1.90884252 |
| 163 | Ocular albinism (HP:0001107) | 1.89897060 |
| 164 | Annular pancreas (HP:0001734) | 1.87703467 |
| 165 | Megalencephaly (HP:0001355) | 1.86930210 |
| 166 | Inappropriate behavior (HP:0000719) | 1.86846709 |
| 167 | Arterial thrombosis (HP:0004420) | 1.86559523 |
| 168 | Vertigo (HP:0002321) | 1.86548636 |
| 169 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85866211 |
| 170 | Impaired vibratory sensation (HP:0002495) | 1.85461329 |
| 171 | Dementia (HP:0000726) | 1.85310548 |
| 172 | Absent speech (HP:0001344) | 1.84489968 |
| 173 | Gangrene (HP:0100758) | 1.83216113 |
| 174 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82335452 |
| 175 | Interstitial pulmonary disease (HP:0006530) | 1.79306475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.46720806 |
| 2 | NTRK3 | 4.38007670 |
| 3 | EPHA4 | 3.39477086 |
| 4 | MAP3K4 | 3.10618296 |
| 5 | MINK1 | 2.88200467 |
| 6 | BLK | 2.81866931 |
| 7 | KSR2 | 2.69465480 |
| 8 | DAPK2 | 2.63219690 |
| 9 | PAK6 | 2.55544835 |
| 10 | MAP2K7 | 2.45867155 |
| 11 | MARK1 | 2.43413449 |
| 12 | TYK2 | 2.41340810 |
| 13 | MAP3K12 | 2.34568775 |
| 14 | RIPK4 | 2.31788085 |
| 15 | PRKD3 | 2.23951718 |
| 16 | IRAK4 | 2.23825052 |
| 17 | CSK | 2.19314392 |
| 18 | FGR | 2.10497915 |
| 19 | CAMKK1 | 2.10349077 |
| 20 | MAP3K14 | 2.03215754 |
| 21 | MAP2K3 | 2.01548587 |
| 22 | NTRK1 | 2.01471604 |
| 23 | ARAF | 2.00249835 |
| 24 | IRAK3 | 1.93386087 |
| 25 | MAP2K4 | 1.92811707 |
| 26 | MAP3K11 | 1.91011895 |
| 27 | MAP4K1 | 1.79396546 |
| 28 | CAMKK2 | 1.74448034 |
| 29 | DAPK1 | 1.73199521 |
| 30 | EPHB1 | 1.72441817 |
| 31 | MAP3K3 | 1.70436762 |
| 32 | MAP3K13 | 1.69066763 |
| 33 | CASK | 1.59946158 |
| 34 | PLK2 | 1.57045052 |
| 35 | MAP3K2 | 1.56645064 |
| 36 | KSR1 | 1.56228272 |
| 37 | ZAP70 | 1.54968816 |
| 38 | STK38 | 1.54556265 |
| 39 | NTRK2 | 1.53953580 |
| 40 | CDK5 | 1.51109462 |
| 41 | MATK | 1.47412296 |
| 42 | GRK5 | 1.46724352 |
| 43 | GRK7 | 1.45823472 |
| 44 | NEK1 | 1.44685758 |
| 45 | TXK | 1.39772724 |
| 46 | PRPF4B | 1.37372534 |
| 47 | JAK2 | 1.37312480 |
| 48 | ERN1 | 1.36514532 |
| 49 | JAK1 | 1.32084622 |
| 50 | SYK | 1.30920974 |
| 51 | TBK1 | 1.28917553 |
| 52 | TGFBR2 | 1.28420683 |
| 53 | CDK19 | 1.27093722 |
| 54 | FES | 1.25750149 |
| 55 | EPHA3 | 1.20237297 |
| 56 | IRAK2 | 1.20220532 |
| 57 | IKBKE | 1.19148208 |
| 58 | PRKCG | 1.18934085 |
| 59 | HCK | 1.16997423 |
| 60 | TAOK2 | 1.16652495 |
| 61 | SCYL2 | 1.13354453 |
| 62 | JAK3 | 1.10294560 |
| 63 | IRAK1 | 1.09840138 |
| 64 | TAOK3 | 1.05624571 |
| 65 | PINK1 | 1.01102932 |
| 66 | SGK223 | 1.00200073 |
| 67 | SGK494 | 1.00200073 |
| 68 | UHMK1 | 1.00078831 |
| 69 | LYN | 0.99227668 |
| 70 | MAP3K1 | 0.99106043 |
| 71 | PRKCH | 0.97940600 |
| 72 | SIK2 | 0.95849464 |
| 73 | ACVR1B | 0.94136599 |
| 74 | RET | 0.94035165 |
| 75 | TAOK1 | 0.93760431 |
| 76 | MARK3 | 0.92629574 |
| 77 | CDK14 | 0.91577147 |
| 78 | CDK18 | 0.88157480 |
| 79 | CDK15 | 0.85622504 |
| 80 | WNK3 | 0.85545730 |
| 81 | MAPK13 | 0.85336450 |
| 82 | CAMK2A | 0.84355093 |
| 83 | ALK | 0.83516003 |
| 84 | LMTK2 | 0.80872556 |
| 85 | MAPK12 | 0.80662454 |
| 86 | MAP3K5 | 0.80452606 |
| 87 | PHKG2 | 0.80398189 |
| 88 | PHKG1 | 0.80398189 |
| 89 | CSF1R | 0.80171909 |
| 90 | YES1 | 0.79072305 |
| 91 | RAF1 | 0.78959671 |
| 92 | PNCK | 0.77565572 |
| 93 | GRK6 | 0.76900721 |
| 94 | SGK2 | 0.76213750 |
| 95 | DDR2 | 0.75918276 |
| 96 | SGK3 | 0.74112013 |
| 97 | LCK | 0.73651024 |
| 98 | IKBKB | 0.72791387 |
| 99 | CDK11A | 0.72595529 |
| 100 | BMPR2 | 0.71756870 |
| 101 | BTK | 0.71715902 |
| 102 | CAMK1 | 0.71667882 |
| 103 | PAK3 | 0.71175982 |
| 104 | FGFR3 | 0.69549857 |
| 105 | RIPK1 | 0.68164054 |
| 106 | OXSR1 | 0.68062378 |
| 107 | PDK1 | 0.66958207 |
| 108 | LATS2 | 0.66645604 |
| 109 | DYRK1A | 0.66522113 |
| 110 | PDPK1 | 0.65947891 |
| 111 | FER | 0.65779666 |
| 112 | STK11 | 0.64349812 |
| 113 | BRAF | 0.64258320 |
| 114 | TYRO3 | 0.63201635 |
| 115 | SGK1 | 0.62802916 |
| 116 | KIT | 0.62610239 |
| 117 | MAP2K6 | 0.61230854 |
| 118 | PTK2B | 0.59613330 |
| 119 | TNIK | 0.56555955 |
| 120 | CAMK2B | 0.56487737 |
| 121 | PRKCE | 0.56194276 |
| 122 | BRSK1 | 0.54928273 |
| 123 | MAP2K1 | 0.53672171 |
| 124 | PDK2 | 0.53261503 |
| 125 | CSNK1G2 | 0.51832605 |
| 126 | TNK2 | 0.51217492 |
| 127 | PRKCZ | 0.48631579 |
| 128 | MAPK7 | 0.48601156 |
| 129 | CCNB1 | 0.47353240 |
| 130 | CAMK4 | 0.47159128 |
| 131 | ITK | 0.46846965 |
| 132 | WNK1 | 0.46729293 |
| 133 | AKT3 | 0.46325600 |
| 134 | CAMK1D | 0.45550562 |
| 135 | RPS6KA3 | 0.45504104 |
| 136 | CAMK2D | 0.45394050 |
| 137 | DAPK3 | 0.43921724 |
| 138 | MAP3K6 | 0.43353277 |
| 139 | NEK6 | 0.43151571 |
| 140 | CDC42BPA | 0.42248572 |
| 141 | MAPK10 | 0.42077468 |
| 142 | PRKD2 | 0.41112083 |
| 143 | NME1 | 0.41020056 |
| 144 | SIK3 | 0.38677202 |
| 145 | FYN | 0.38397862 |
| 146 | CAMK2G | 0.37510890 |
| 147 | RPS6KA2 | 0.37291044 |
| 148 | HIPK2 | 0.36629258 |
| 149 | TESK2 | 0.36365070 |
| 150 | MARK2 | 0.34707446 |
| 151 | MOS | 0.32889652 |
| 152 | WNK4 | 0.30894788 |
| 153 | PRKCB | 0.30885807 |
| 154 | CAMK1G | 0.29230482 |
| 155 | PRKCA | 0.28826309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.03794692 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.37720437 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73117045 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72143737 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59577361 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.53778453 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.51207242 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45297078 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.41559986 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41259107 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37723809 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.35175987 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29927261 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.20129693 |
| 15 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.19874772 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.18054372 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.16060735 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15987956 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.13915708 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03150423 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.93508532 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80200823 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70637461 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69752051 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.66122641 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.63114195 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61132638 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.58781065 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.58199143 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.58101437 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.57345851 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55549785 |
| 33 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52661613 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50338229 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49197365 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46699126 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45968789 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.45758087 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45424031 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44463349 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.43479178 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.43319354 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42552188 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37121708 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30206792 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30120496 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30078347 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29336674 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29023091 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28881858 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27485785 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25293629 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23522010 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21973341 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21794231 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.19137860 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15333446 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14999430 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.09538381 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07588512 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 1.06617308 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06102326 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05265955 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03482352 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03296081 |
| 66 | Glioma_Homo sapiens_hsa05214 | 1.03038152 |
| 67 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01803012 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 1.00905349 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99523563 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98280488 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.94818361 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93080603 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92713830 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.92173450 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90014819 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89903409 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.89186507 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88733540 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85940546 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83400339 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83002186 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80549522 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78803512 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78614703 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.78413621 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.77860694 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76358725 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76127171 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.75927998 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75018125 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73356177 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72771947 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72564244 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72029344 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69670469 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69043686 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68641920 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67483029 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67426109 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.67295245 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66765313 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66343799 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66153879 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.66054254 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.64601531 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63723807 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.63431369 |
| 108 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61827188 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61024084 |
| 110 | * Phagosome_Homo sapiens_hsa04145 | 0.60574588 |
| 111 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60359805 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59893302 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58765565 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58085729 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57543888 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57409249 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57227998 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.56128744 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56027660 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56008319 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55987609 |
| 122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55560874 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53724549 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52626356 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.51329249 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.50581511 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49574197 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46917352 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46114280 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44008021 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43803653 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42556504 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42541104 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.42014821 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41992922 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.40780671 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38920971 |
| 138 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38039197 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37858828 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36504922 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36270538 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35644638 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35430842 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.34838050 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.34181754 |
| 146 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33490110 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30482109 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30232961 |
| 149 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30179269 |

